Manufacturer
Intra-Cellular Therapies
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 3
- Molecules
- 1
- Therapy areas
- 0
Intra-Cellular Therapies is a pharmaceutical manufacturer based in United States. MedsAcross lists 3 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Intra-Cellular Therapies, Inc
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Intra-Cellular Therapies products through licensed channels, with the documents your regulator needs.
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Caplyta 10.5 mg capsuleOral | Lumateperone | US FDA | Available on request |
| Caplyta 21 mg capsuleOral | Lumateperone | US FDA | Available on request |
| Caplyta 42 mg capsuleOral | Lumateperone | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Intra-Cellular Therapies
Send a request for any of these products. We confirm the licensed source, documents and lead time.